Common Contracts

COHBAR, INC. 20,833,334 Shares of Common Stock (par value $0.001 per share) and Warrants to Purchase 20,833,334 Shares of Common Stock Underwriting Agreement

Underwriting Agreement • October 28th, 2021 • CohBar, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  October 28th, 2021
• Company
  CohBar, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

CohBar, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of 20,833,334 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), and (ii) warrants of the Company to purchase an aggregate of 20,833,334 shares of Common Stock (the “Warrants”). Each Share is being sold together with one Warrant; and each full Warrant is exercisable for one Common Share at an exercise price of $0.72 per whole share. The Shares and the Warrants to be sold by the Company are collectively called the “Offered Securities.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Securities. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as used herein shall mean Cantor, as Underwriter,

●] SHARES INHIBRX, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT

Underwriting Agreement • August 12th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Underwriting Agreement
• Filed
  August 12th, 2020
• Company
  Inhibrx, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

4,500,000 Shares Eiger BioPharmaceuticals, Inc. Common Stock, $0.001 par value per share UNDERWRITING AGREEMENT

Underwriting Agreement • April 22nd, 2019 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Underwriting Agreement
• Filed
  April 22nd, 2019
• Company
  Eiger BioPharmaceuticals, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

Eiger BioPharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,500,000 shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriters an option to purchase up to 675,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”